International troika drives biomanufacturing platforms

GE Healthcare has teamed with Sweden's iBio and the Fraunhofer Center for Molecular Biotechnology to develop biopharma and vaccine manufacturing gear. The arrangement capitalizes on GE's global life sciences muscle, the iBioLaunch plant-based vaccine and therapeutic protein manufacturing platform, and Fraunhofer's vaccine and molecular biology expertise. GE will supply bioprocessing products and process expertise for integration with the iBioLaunch platform. It will also support the development of products based on the iBioLaunch platform and product offering. iBio release

Suggested Articles

Lonza CEO Marc Funk is leaving for "personal reasons" after less than a year in the top job. 

Drugmakers have voluntarily recalled their generic Zantac from the U.S. market after the FDA raised concerns, but it has not been without a cost.

Just weeks after selling the sterile manufacturing assets of its Kyowa operation in Japan, it has unloaded the rest of its Kyowa drugmaking operation.